HCPCS Code J7188

Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.
Code effective Jan 01, 2016

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J7188 is a valid 2026 HCPCS code meaning Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u. or (Factor viii recomb obizur) for short. HCPCS J7188 has been effective since 01/01/2016 and applies to Medical care.

HCPCS Code Details - J7188

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J7188
Description

Long description:
Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.

Short description:
Factor viii recomb obizur

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code D - Special coverage instructions apply
ASC payment group code Effective Jan 01, 2016 - This procedure is approved to be performed in an ambulatory surgical center.
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2016
Date added Added Jan 01, 2016

See also

  • HCPCS J7187 · Injection, von willebrand factor complex (humate-p), per iu vwf:rco

  • HCPCS C9136 · Injection, factor viii, fc fusion protein, (recombinant), per i.u.

  • HCPCS C9137 · Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.

  • HCPCS C9138 · Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.

  • HCPCS C9140 · Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.

  • HCPCS C9141 · Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.

  • HCPCS J7182 · Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu

  • HCPCS J7185 · Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.

  • HCPCS J7204 · Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu

  • HCPCS J7205 · Injection, factor viii fc fusion protein (recombinant), per iu

  • HCPCS J7207 · Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.

  • HCPCS J7208 · Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.

  • HCPCS J7209 · Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.

  • HCPCS J7210 · Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.

  • HCPCS J7211 · Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.

  • HCPCS J7214 · Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.

  • HCPCS J7189 · Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.